Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
PCR: Page 3
Servier, Qiagen partner to develop companion diagnostic test for AML
By
LabPulse.com staff writers
Under a master collaboration agreement, Qiagen will develop and validate a real-time PCR-based in vitro diagnostic test that can be used to detect IDH1 gene mutations in whole blood and bone marrow aspirates in AML.
March 9, 2023
Virufy nabs BARDA contract to develop cough- and speech-based COVID-19 detection technology
By
LabPulse.com staff writers
The project supports the firm’s aim to research and develop COVID-19 screening tools using artificial intelligence (AI)/machine learning (ML) technology.
March 8, 2023
Bio-Rad Laboratories revenue growth flat in Q4
By
LabPulse.com staff writers
Revenue increased almost 11% on a currency-neutral basis when COVID-related sales comparisons were excluded.
February 17, 2023
LumiraDx obtains FDA authorization for test to detect flu A, flu B, SARS-CoV-2
By
LabPulse.com staff writers
The test leverages a single-step direct method for nucleic acid extraction and amplification on validated open RT-PCR instruments.
February 7, 2023
Thermo Fisher Scientific obtains FDA EUA for monkeypox/orthopox virus DNA kit
By
LabPulse.com staff writers
The test is intended for the qualitative detection of DNA from monkeypox virus (clade I/II) and screening for non-variola orthopoxviruses in human lesion swab specimens.
December 15, 2022
BioGX launches portable qPCR platform with CE-IVD marked assays outside U.S.
By
LabPulse.com staff writers
The expanded availability of its products complements a recent FDA expanded Emergency Use Authorization for the Xfree COVID-19 Direct RT-PCR running on the portable PCR platform.
December 12, 2022
Cepheid says its influenza assays mitigate impact of mutational drift seen in some tests
By
LabPulse.com staff writers
Two mutations in the matrix genes of the human influenza A virus have been reported to cause matrix gene target failure for several commercial diagnostic tests.
December 8, 2022
Eurofins launches droplet digital PCR assay to detect SARS-CoV-2 variants of concern in wastewater
By
LabPulse.com staff writers
The assay detects Omicron subvariants BQ.1 and BQ.1.1, which currently make up more than 35% of the SARS-CoV-2 virus variant distribution in the U.S. and which are increasing at rates superseding all other current SARS-CoV-2 variants, the firm noted.
December 5, 2022
High-throughput lab near UPS facility to provide rapid PCR test results
By
LabPulse.com staff writers
HealthTrackRx has opened a high-throughput laboratory in Clarksville, IN, to enable the rapid delivery of PCR test results.
November 18, 2022
Roche obtains FDA authorization for monkeypox test on high-throughput MDx system
By
LabPulse.com staff writers
Roche's Cobas MPXV test targets two different regions of the MPXV genome which are both less prone to mutations than other parts of the genome, the firm said.
November 16, 2022
Sentinel Diagnostics launches automated PCR system and assays to detect viral infections
By
LabPulse.com staff writers
Its Stat-Nat SN200 kits leverage freeze-dried technology that allows long-term stability at room temperature for the quantitative detection of ten viruses, Sentinel said.
November 14, 2022
PerkinElmer nabs first FDA authorization for assay to screen for spinal muscular atrophy in newborns
By
LabPulse.com staff writers
The assay may be used by certified laboratories for the simultaneous detection of spinal muscular atrophy and severe combined immunodeficiency in newborns.
November 14, 2022
Previous Page
Page 3 of 23
Next Page
